InvestorInvesting in private markets for over 30 years.

Sofinnova Investments is a Menlo Park-based healthcare investment firm specializing in early-stage investments in life sciences companies, particularly in therapeutic drugs. Founded in 1976, it manages approximately $3.3 billion in assets.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Sofinnova Investments, founded in 1976 and headquartered in Menlo Park, California, is a prominent venture capital firm focused on healthcare investments. With approximately $3.3 billion in assets under management, Sofinnova specializes in early-stage investments in life sciences companies, particularly those developing innovative therapeutic drugs. The firm emphasizes company building and supports biotech entrepreneurs throughout the drug discovery and development process, guiding them through regulatory approval and market entry. Sofinnova's investment strategy targets late preclinical and clinical-stage companies across the United States and Europe, with key therapeutic areas including oncology, respiratory, dermatology, ophthalmology, neurology, and women's health.
Sofinnova Investments invests in late preclinical and clinical therapeutic companies across the United States and Europe. The firm targets key therapeutic areas including oncology, respiratory, dermatology, ophthalmology, neurology, and women's health, aiming to support entrepreneurs in their journey to bring innovative therapies to market.
Sofinnova Investments adds value to its portfolio companies by providing not only financial capital but also strategic guidance in drug development, regulatory navigation, and preparation for IPOs. The firm emphasizes a hands-on approach to support entrepreneurs in achieving their milestones.
Sofinnova Investments focuses on late preclinical and clinical therapeutic companies in North America and Europe. The firm seeks to invest in key therapeutic areas such as oncology, respiratory, dermatology, ophthalmology, neurology, and women's health. They look for credible teams with a clear unmet medical need and a viable path through regulatory and capital-markets milestones.
Founders interested in pitching to Sofinnova should prepare a detailed presentation that outlines their therapeutic innovation, market potential, and regulatory strategy. While specific submission processes are not disclosed, a warm introduction through industry connections may enhance the chances of engagement.
Sofinnova Investments distinguishes itself through its deep focus on life sciences and therapeutic drug development. The firm emphasizes a hands-on approach, providing not only capital but also strategic guidance in drug development and regulatory navigation, which is critical for success in the biotech sector.
The firm primarily invests in companies located in North America and Europe, allowing it to leverage its expertise and network in these regions to support portfolio companies effectively.
While specific check sizes are not disclosed, Sofinnova Investments invests across various stages, from pre-seed to IPO, indicating a flexible approach to funding based on the needs of the portfolio companies.
Sofinnova Investments offers extensive post-investment support, including strategic guidance in drug development, regulatory navigation, and preparation for IPOs. The firm actively participates in the growth of its portfolio companies, ensuring they achieve their milestones.
Superscout Pro
Is this page right?Reviewed · How the research works